Table 2.
Subcategories | Preoperative | Follow-up at 10–16 years | Δ (points) | |
---|---|---|---|---|
HOOS total score (0–100) | 32.25% (σ = 14.07) | 91.91% (σ = 9.13) | 59.66 | |
S (Symptoms & Stiffness) | 32.94% (σ = 15.69) | 89.68% (σ = 12.14) | 56.74 | |
P (Pain) | 33.25% (σ = 18.80) | 94.37% (σ = 7.28) | 61.12 | |
A (Function, daily living) | 33.29% (σ = 14.45) | 80.16% (σ = 8.19) | 46.87 | |
SP (Function, sports and recreational activities) | 22.04% (σ = 17.95) | 85.17% (σ = 13.65) | 62.77 | |
Q (Quality of life) | 19.94% (σ = 16.51) | 74.42% (σ = 19.03) | 54.48 | |
SF12 PCS score | 36.08% (σ = 9.14) | 54.15% (σ = 8.52) | 18.07 | |
SF12 MCS score | 28.57% (σ = 9.93) | 47.09% (σ = 5.96) | 18.52 |
Clinical outcome of patients treated with the Nanos total hip implant, assessed through Hip disability and Osteoarthritis Outcome Score (HOOS) and Short Form Survey (SF-12) Abbreviations: HOOS Hip Disability and Osteoarthritis Outcome, SF12 Short Form Survey, PCS Physical score, MCS Mental score, standard deviation